AAR and Air France Industries KLM Engineering & Maintenance to form joint venture in Asia-Pacific region
WOOD DALE, Ill. and PARIS and AMSTELVEEN, Netherlands and CHONBURI, Thailand, Dec. 12, 2024 /PRNewswire/ -- AAR CORP. (NYSE: AIR), a leading provider of aviation services to commercial and government operators, MROs, and OEMs, and Air France...
A New Era of Customer-Centricity with IFF Pharma Solutions' AnswerCenter Platform
Web-based customer platform provides answers at customers' fingertips NEW YORK, Dec. 12, 2024 /PRNewswire/ -- IFF (NYSE:IFF) Pharma Solutions announces the launch of its new customer experience platform, AnswerCenter. This customized environment is...
Hyundai Mobis to Showcase World's First Full-Windshield Holographic Display at CES 2025
The groundbreaking display projects critical driving information across the entire width of the windshield, offering a panoramic and immersive experience that spans from the driver's seat to the passenger's seat. Hyundai Mobis will also present its...
Ascenda Partners with Cardless to Transform Co-Brand Landscape and Enable New Loyalty Opportunities
NEW YORK, Dec. 12, 2024 /PRNewswire/ -- Ascenda, the industry leader in loyalty as a service, today announced a strategic partnership with Cardless, a digital-first credit card platform, aimed at transforming the co-branded credit card and loyalty...
Porton Pharma Solutions and Aojin Life Sciences Announce Strategic Collaboration to Advance XDC Conjugate Drugs for Dual IND Filings in China and the U.S.
CHONGQING, China, Dec. 12, 2024 /PRNewswire/ -- Recently, Porton Pharma Solutions Ltd. ("Porton") announced a strategic partnership with Aojin Life Sciences (Yixing) Co., Ltd. ("Aojin Life Sciences"). Porton will provide comprehensive CDMO services...
CureGene Received Clinical Trial Approval in China for CG-0255 for Injection - A Novel Antiplatelet Therapy
SHANGHAI, Dec. 12, 2024 /PRNewswire/ -- CureGene Pharmaceutical ("CureGene"), a biotechnology company dedicated to innovative treatments for critical unmet medical needs in cardio-cerebrovascular and antiviral disease, proudly announces the approval...
SK bioscience Receives Approval for Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate
SK bioscience's first mRNA vaccine candidate is expected to enter clinical trials in Australia in February 2025, with interim results expected by 2026. Joint R&D project between SK and CEPI includes up to USD 40 million in initial funding...
Xinhua Silk Road: Exploring charm of intangible cultural heritage in Minhang District of Shanghai
BEIJING, Dec. 12, 2024 /PRNewswire/ -- The city of Shanghai is a first choice for many foreign tourists to learn about China. Join us in a video tour to Minhang District in Shanghai and explore the charm of intangible cultural heritage. The Maqiao...